CHARLAI BREEDING: Open Payments
NPI 1477262954 · BIRMINGHAM, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,983 in 156 payments from 23 companies in 2025. Trend: 2023 $0 · 2024 $1,051 · 2025 $2,983
Food & beverage: $2,983
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 20 | $322 |
| QOL Medical, LLC | 12 | $308 |
| GENZYME CORPORATION | 11 | $275 |
| Lilly USA, LLC | 13 | $241 |
| Regeneron Healthcare Solutions, Inc. | 10 | $236 |
| Ardelyx, Inc. | 9 | $207 |
| Madrigal Pharmaceuticals | 9 | $183 |
| Takeda Pharmaceuticals U.S.A., Inc. | 12 | $178 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 11 | $167 |
| Janssen Biotech, Inc. | 8 | $145 |
Products named: DUPIXENT, Sucraid, OMVOH, IBSRELA, REZDIFFRA, TREMFYA, CREON, IQIRVO.
Industry payments across AL — which companies pay providers there.
